Revealing Disease
Architecture Through Spatial Proteomics

spatioProteome project screenshot
SpatioProteome.Ai about image
About Our Platform

High-Resolution Cellular Mapping from Proteome Data

SpatioProteome.Ai is a spatial proteomics platform that reconstructs tissue architecture by analyzing protein expression and cellular localization. Unlike conventional bulk or single-cell approaches, it delivers a more holistic understanding of how different cell types are organized within a tissue and how they interact over time, particularly under disease conditions or therapeutic influence.

Why Use SpatioProteome.Ai

Bridging the Gaps in Disease Understanding

Traditional proteomics techniques often fail to capture the spatial complexity and heterogeneity of diseased tissues. SpatioProteome.Ai addresses this limitation by mapping cell types, phenotypes, and functional states within their native environments.
This spatial intelligence is critical in understanding why therapies succeed or fail, and when intervention is most effective. It also enables the discovery of prognostic and predictive biomarkers by tracking how cellular composition changes over time—making it invaluable for clinical research, translational science, and drug development.

HOW IT WORKS

Marker-Based Cell Segmentation
and Phenotyping

The platform uses high-resolution imaging and proteomic data to segment individual cells and annotate them based on protein marker expression. Through this, SpatioProteome.Ai generates spatial maps of cellular phenotypes, distribution, and interactions across tissue environments. This allows precise monitoring of cellular state changes over time and across conditions.

Key Features & Capabilities

High-Resolution Cellular Mapping

Builds spatial maps of tissue architecture by identifying and locating cell types using protein expression patterns.

Cell Segmentation and Phenotyping

Uses marker-based pipelines to segment cells and define their phenotypes in situ.

Dynamic Disease Insight

Tracks how cell composition and functional states change across disease stages or therapeutic interventions.

Biomarker Discovery

Identifies spatially localized prognostic and predictive biomarkers that are invisible in bulk analyses.

Therapeutic Response Analysis

Reveals spatial signatures linked to therapy resistance, efficacy, and relapse potential.

Supports Prognosis and Stratification

Enhances precision medicine by providing actionable insight into disease subtypes and progression risks.

Contact Us

Would you like us to get in touch with you? Fill up the form & we will reach out to you